Delivery Order SPE2DB24D1205-SPE2DB25FCVQR
Award Date
4/7/25
Potential Completion Date
4/8/25
Potential Value
$20K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,887.46, is for the delivery of 4564466378 - BUPROPION HCL XL 300 MG TABLET 500S. It is a Firm Fixed Price delivery order contract type with a performance period through May 2, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a larger...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,916.92, is a firm fixed-price delivery order for the supply of 4565058004 - Bupropion HCL XL 300 mg Tablets in 500 count bottles. The contract has an ultimate completion date of July 3, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,487.12 firm fixed-price delivery order is for the supply of 4,567,379,185 units of Bupropion HCL XL 300 mg tablets. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of bupropion HCL XL 300 mg tablets. The contract, valued at $7,995.47, was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of April 1, 2025. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,941.18, is a delivery order for 4562926146 - Bupropion HCL XL 150 mg Tablets, 500 count. The contract has a firm fixed price and an ultimate completion date of November 29, 2023. The contract is not designated as a set-aside award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award, valued at $13,575.42, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4563654049 - BUPROPION HCL XL 300 MG TABLET 500S, with an ultimate completion date of February 14, 2024. The contract is a firm fixed-price award and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of BUPROPION HCL XL 300 MG TABLET 500S. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $105,516.75 and a performance period ending on February 21, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,366.13 firm fixed-price delivery order is for the supply of 4,563,851,552 units of Bupropion HCL XL 150 mg tablets. The contract has an ultimate completion date of March 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $24,274.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of 4563518617 BUPROPION HCL XL 300 MG TABLET 500S. The contract is a firm-fixed-price delivery order with a completion date of February 2, 2024. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, is the prime contractor and there are no subcontractors mentioned. This contract award is not designated as a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $38,545.95 fixed-price delivery order is for the supply of 4563637495 BUPROPION HCL XL 150 MG TABLET 500S, with a period of performance through February 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...